Skip to main content
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.62
+1.08 (4.07%)
At close: Mar 9, 2026, 4:00 PM EDT
27.69
+0.07 (0.25%)
After-hours: Mar 9, 2026, 5:09 PM EDT

Beam Therapeutics Revenue

In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth. Beam Therapeutics had revenue of $114.11M in the quarter ending December 31, 2025, with 279.52% growth.

Revenue (ttm)
$139.74M
Revenue Growth
+120.01%
P/S Ratio
19.61
Revenue / Employee
$273,470
Employees
511
Market Cap
2.74B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025139.74M76.23M120.01%
Dec 31, 202463.52M-314.19M-83.18%
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Apellis Pharmaceuticals 1.00B
Telix Pharmaceuticals 803.79M
Travere Therapeutics 490.73M
Arcus Biosciences 247.00M
IDEAYA Biosciences 218.71M
Viridian Therapeutics 70.85M
Tango Therapeutics 62.38M
Wave Life Sciences 42.73M
Revenue Rankings

BEAM News

More News